--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About FDMT20260417C11
Biological Technology
4D Molecular Therapeutics, Inc., was incorporated under the laws of the State of Delaware on March 11, 2015. The Company is a leading clinical-stage biopharmaceutical company focused on unlocking the full potential of genetic medicines through proprietary custom vectors optimized for disease-specific treatments.
